Scott and John discuss the impact of artificial intelligence (AI) on the biotech industry. They explore how AI is revolutionizing drug discovery and development, as well as its applications in commercialization and personalized medicine. The hosts also highlight the integration of AI into biopharma systems and the potential for AI to enhance diagnostic possibilities. They emphasize that while AI will transform various fields, it cannot replace human expertise. The episode concludes with a call to action for listeners to engage with the podcast and share their thoughts on AI's impact.